title: Intra-cochlear trafficking of aminoglycosides.
abstract: Cochlear sensory hair cells are pharmacologically sensitive to aminoglycoside antibiotics that are used for treating life-threatening bacterial sepsis. Cochlear tissues are compartmentalized behind an impermeable paracellular barrier called the blood-labyrinth barrier (BLB). Most macromolecules cannot cross the blood-labyrinth barrier; however, aminoglycosides can cross this barrier into the cochlear fluids and enter hair cells, inducing hair cell death and consequent permanent hearing loss or deafness. The trafficking routes and cellular mechanisms required for aminoglycoside trafficking across the blood-labyrinth barrier remain unknown.Aminoglycosides enter cochlear hair cells across their apical membranes that are bathed in endolymph, a hitherto unexpected trafficking route. The stria vascularis, a component of the blood- labyrinth barrier, preferentially loads with aminoglycosides. Our recent work demonstrates that the stria vascularis exhibits high expression of the cation-selective ion channel TRPV4, and that this channel is permeable to aminoglycosides. However, aminoglycosides must employ more than one cellular mechanism to cross the blood-labyrinth barrier into endolymph against the electrical gradient.
authors.affiliation: Oregon Hearing Research Center; Oregon Health and Science University; Portland, Oregon USA.
authors.forename: Peter S
authors.initials: PS
authors.lastname: Steyger
authors.forename: Takatoshi
authors.initials: T
authors.lastname: Karasawa
references.citation: J Physiol. 2005 Sep 1;567(Pt 2):505-21
references.pmid: 15994187
references.citation: J Infect Dis. 1981 Mar;143(3):476-86
references.pmid: 7229440
references.citation: J Assoc Res Otolaryngol. 2003 Dec;4(4):565-78
references.pmid: 14605921
references.citation: Hear Res. 2006 Mar;213(1-2):64-78
references.pmid: 16466873
references.citation: Hear Res. 2005 Jun;204(1-2):170-82
references.pmid: 15925202
references.citation: Nature. 1997 Oct 23;389(6653):816-24
references.pmid: 9349813
references.citation: Antimicrob Agents Chemother. 1983 Feb;23(2):344-6
references.pmid: 6838193
references.citation: Brain Res. 1995 Dec 15;704(1):135-40
references.pmid: 8750975
references.citation: J Physiol. 2004 Aug 1;558(Pt 3):769-92
references.pmid: 15181168
references.citation: EMBO Rep. 2008 May;9(5):472-9
references.pmid: 18323855
references.citation: Acta Otolaryngol. 1992;112(2):272-7
references.pmid: 1604991
references.citation: Am J Physiol Cell Physiol. 2007 Oct;293(4):C1187-208
references.pmid: 17670895
references.citation: J Cell Sci. 2008 Sep 1;121(Pt 17):2871-9
references.pmid: 18682499
references.citation: Neuroreport. 2006 Feb 6;17(2):135-9
references.pmid: 16407759
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1751-6
references.pmid: 18218777
references.citation: J Neurosci. 2001 Sep 15;21(18):7013-25
references.pmid: 11549711
references.citation: Hear Res. 2008 Jan;235(1-2):114-24
references.pmid: 18082985
references.citation: Cell. 2000 Oct 27;103(3):525-35
references.pmid: 11081638
references.citation: Hear Res. 1989 Feb;37(3):203-17
references.pmid: 2468634
references.citation: Acta Otolaryngol Suppl. 1988;447:28-35
references.pmid: 3055805
references.citation: Acta Otolaryngol. 2005 Sep;125(9):929-34
references.pmid: 16193584
references.citation: J Cell Biol. 2008 Aug 11;182(3):437-47
references.pmid: 18695040
references.citation: Hear Res. 2005 Jun;204(1-2):156-69
references.pmid: 15925201